Cargando…

PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells

PARP-1 inhibition has recently been employed in both mono- and combination therapies in various malignancies including melanoma with both promising and contradicting results reported. Although deeper understanding of the underlying molecular mechanisms may help improving clinical modalities, the com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cseh, Anna Maria, Fabian, Zsolt, Quintana-Cabrera, Ruben, Szabo, Aliz, Eros, Krisztian, Soriano, Maria Eugenia, Gallyas, Ferenc, Scorrano, Luca, Sumegi, Balazs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514236/ https://www.ncbi.nlm.nih.gov/pubmed/31133874 http://dx.doi.org/10.3389/fphys.2019.00538

Ejemplares similares

Role of Akt Activation in PARP Inhibitor Resistance in Cancer
por: Gallyas, Ferenc, et al.
Publicado: (2020)

PARP Inhibition Attenuates Acute Kidney Allograft Rejection by Suppressing Cell Death Pathways and Activating PI-3K-Akt Cascade
por: Kalmar-Nagy, Karoly, et al.
Publicado: (2013)

Mitochondrial Protection by PARP Inhibition
por: Gallyas Jr., Ferenc, et al.
Publicado: (2020)

Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation
por: Radnai, Balazs, et al.
Publicado: (2012)

Antioxidant and Anti-Inflammatory Effects in RAW264.7 Macrophages of Malvidin, a Major Red Wine Polyphenol
por: Bognar, Eszter, et al.
Publicado: (2013)

BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species
por: Sumegi, Katalin, et al.
Publicado: (2017)

Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats
por: Eros, Krisztian, et al.
Publicado: (2017)

Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors
por: Cseh, Anna Mária, et al.
Publicado: (2017)

Role of Mitochondrial Network Stabilisation by a Human Small Heat Shock Protein in Tumour Malignancy
por: Turi, Zsuzsanna, et al.
Publicado: (2015)

PARP-Inhibitor Treatment Prevents Hypertension Induced Cardiac Remodeling by Favorable Modulation of Heat Shock Proteins, Akt-1/GSK-3β and Several PKC Isoforms
por: Deres, Laszlo, et al.
Publicado: (2014)

Temporal progression of PARP activity in the Prph2 mutant rd2 mouse: Neuroprotective effects of the PARP inhibitor PJ34
por: Sahaboglu, Ayse, et al.
Publicado: (2017)

Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells
por: Bai, Xue Tao, et al.
Publicado: (2015)

Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure
por: Riba, Adam, et al.
Publicado: (2017)

The Mitochondrial Targets of Neuroprotective Drug Vinpocetine on Primary Neuron Cultures, Brain Capillary Endothelial Cells, Synaptosomes, and Brain Mitochondria
por: Svab, Gergely, et al.
Publicado: (2019)

Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines
por: Andreidesz, Kitti, et al.
Publicado: (2021)

Cyclophilin D‐dependent mitochondrial permeability transition amplifies inflammatory reprogramming in endotoxemia
por: Veres, Balazs, et al.
Publicado: (2021)

PARP Inhibitor PJ34 Suppresses Osteogenic Differentiation in Mouse Mesenchymal Stem Cells by Modulating BMP-2 Signaling Pathway
por: Kishi, Yuta, et al.
Publicado: (2015)

Amiodarone’s major metabolite, desethylamiodarone inhibits proliferation of B16-F10 melanoma cells and limits lung metastasis formation in an in vivo experimental model
por: Bognar, Zita, et al.
Publicado: (2020)

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
por: Maillet, M., et al.
Publicado: (2013)

PJ accu (?)
Publicado: (1989)

Influence of PJ34 on the genotoxicity induced by melphalan in human multiple myeloma cells
por: Xiong, Ting, et al.
Publicado: (2015)

PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD(+) levels and increasing SIRT1 activity
por: Zha, Siyuan, et al.
Publicado: (2018)

Traveling Bax and Forth from Mitochondria to Control Apoptosis
por: Soriano, Maria Eugenia, et al.
Publicado: (2011)

Correction to: PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD(+) levels and increasing SIRT1 activity
por: Zha, Siyuan, et al.
Publicado: (2018)

Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34
por: Shen, Yan, et al.
Publicado: (2016)

The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts
por: Visochek, Leonid, et al.
Publicado: (2019)

Correlation between the progressive cytoplasmic expression of a novel small heat shock protein (Hsp16.2) and malignancy in brain tumors
por: Pozsgai, Eva, et al.
Publicado: (2007)

The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer Cells
por: Cohen-Armon, Malka
Publicado: (2020)

Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts
por: Visochek, Leonid, et al.
Publicado: (2020)

Novel Mechanisms of Sildenafil in Pulmonary Hypertension Involving Cytokines/Chemokines, MAP Kinases and Akt
por: Kiss, Tamas, et al.
Publicado: (2014)

BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats
por: Horvath, Orsolya, et al.
Publicado: (2021)

Involvement of Mitochondrial Mechanisms in the Cytostatic Effect of Desethylamiodarone in B16F10 Melanoma Cells
por: Ramadan, Fadi H. J., et al.
Publicado: (2020)

Proteomic changes during experimental de- and remyelination in the corpus callosum
por: Szilagyi, Gabor T., et al.
Publicado: (2020)

The Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitor PJ34 Reduces Pulmonary Ischemia-Reperfusion Injury in Rats
por: Hatachi, Go, et al.
Publicado: (2014)

763 The Cardioprotective Effects of Sildenafil, PJ34, MitoTEMPO, and ZLN005 in the Early After Burn Injury
por: Radhakrishnan, Ravi, et al.
Publicado: (2023)

Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing’s Sarcoma
por: Gill, Sonja J., et al.
Publicado: (2015)

Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells
por: Kovács, Dominika, et al.
Publicado: (2021)

Upregulation of Salmonella-Induced IL-6 Production in Caco-2 Cells by PJ-34, PARP-1 Inhibitor: Involvement of PI3K, p38 MAPK, ERK, JNK, and NF-κB
por: Huang, Fu-Chen
Publicado: (2009)

Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Reduces Brain Damage after Stroke in the Neonatal Mouse Brain
por: Bonnin, Philippe, et al.
Publicado: (2021)

Remodeling of Liver and Plasma Lipidomes in Mice Lacking Cyclophilin D
por: Koszegi, Balazs, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g68s3mb8hllc28a3l2id2ov2ib